Russell Investments Group, Ltd. Unity Biotechnology, Inc. Transaction History

Russell Investments Group, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$1.3 - $3.17 $45,123 - $110,030	-34,710 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$2.91 - $4.5 $202,815 - $313,632	-69,696 Reduced 66.75%	34,710 $103,000
Q2 2021 Aug 04, 2021	SELL	$4.15 - $6.3 $334,780 - $508,221	-80,670 Reduced 43.59%	104,406 $481,000
Q1 2021 May 10, 2021	SELL	$5.51 - $9.42 $439,879 - $752,026	-79,833 Reduced 30.14%	185,076 $1.11 Million
Q4 2020 Feb 08, 2021	BUY	$3.42 - $6.36 $236,944 - $440,633	69,282 Added 35.42%	264,909 $1.39 Million
Q3 2020 Nov 09, 2020	SELL	$2.94 - $12.43 $60,031 - $253,808	-20,419 Reduced 9.45%	195,627 $675,000
Q2 2020 Aug 05, 2020	SELL	$5.28 - $9.67 $34,525 - $63,232	-6,539 Reduced 2.94%	216,046 $1.88 Million
Q1 2020 May 06, 2020	BUY	$5.0 - $7.6 $742,120 - $1.13 Million	148,424 Added 200.14%	222,585 $1.29 Million
Q4 2019 Jan 29, 2020	BUY	$5.99 - $8.38 $269,579 - $377,141	45,005 Added 154.36%	74,161 $534,000
Q3 2019 Nov 01, 2019	BUY	$5.62 - $9.63 $163,856 - $280,772	29,156 New	29,156 $178,000
Q1 2019 May 13, 2019	SELL	$7.65 - $16.66 $105,409 - $229,558	-13,779 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$10.76 - $17.25 $148,262 - $237,687	13,779 New	13,779 $226,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $17M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.